MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer.
about
Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applicationsRecent advances in mass spectrometry-based proteomics of gastric cancerMass spectrometry imaging with high resolution in mass and space.Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research.Top-down proteomics with mass spectrometry imaging: a pilot study towards discovery of biomarkers for neurodevelopmental disordersMALDI FTICR IMS of Intact Proteins: Using Mass Accuracy to Link Protein Images with Proteomics DataQuantitative proteomic analysis of gastric cancer tissue reveals novel proteins in platelet-derived growth factor b signaling pathwayHFIP extraction followed by 2D CTAB/SDS-PAGE separation: a new methodology for protein identification from tissue sections after MALDI mass spectrometry profiling for personalized medicine researchMatrix assisted laser desorption ionization mass spectrometry imaging identifies markers of ageing and osteoarthritic cartilage.Imaging mass spectrometry in papillary thyroid carcinoma for the identification and validation of biomarker proteins.Matrix-assisted laser desorption ionization-imaging mass spectrometry: a new methodology to study human osteoarthritic cartilage.Matrix-assisted laser desorption/ionization imaging protocol for in situ characterization of tryptic peptide identity and distribution in formalin-fixed tissue.Repeat MALDI MS imaging of a single tissue section using multiple matrices and tissue washes.Current frontiers in clinical research application of MALDI imaging mass spectrometry.Comprehensive identification of proteins from MALDI imaging.Treatment of nasopharyngeal carcinoma cells with the histone-deacetylase inhibitor abexinostat: cooperative effects with cis-platin and radiotherapy on patient-derived xenografts.Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry.De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry.Proteomic and metabolic prediction of response to therapy in gastric cancer.High-resolution MALDI mass spectrometric imaging of lipids in the mammalian retina.MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice.Filter-Dense Multicolor MicroscopyImaging phosphorylated peptide distribution in human lens by MALDI MS.Recent progress in protein profiling of clinical tissues for next-generation molecular diagnostics.MALDI mass spectrometry imaging analysis of pituitary adenomas for near-real-time tumor delineationCRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients.Langartech: A Custom-Made MALDI Matrix Sprayer for MALDI Imaging Mass Spectrometry.Progress in the development of protein biomarkers of oesophageal and gastric cancers.The use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers.MALDI imaging mass spectrometry as a novel tool for detecting histone modifications in clinical tissue samples.What gastric cancer proteomic studies show about gastric carcinogenesis?MALDI mass spectrometry imaging: A cutting-edge tool for fundamental and clinical histopathology.MALDI Mass Spectrometry Imaging Reveals Decreased CK5 Levels in Vulvar Squamous Cell Carcinomas Compared to the Precursor Lesion Differentiated Vulvar Intraepithelial Neoplasia.High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue.MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.A technique for relative quantitation of cancer biomarkers in formalin-fixed, paraffin-embedded (FFPE) tissue using stable-isotope-label based mass spectrometry imaging (SILMSI).The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancerA new look at drugs targeting malignant melanoma--an application for mass spectrometry imaging.Molecular histology of arteries: mass spectrometry imaging as a novel ex vivo tool to investigate atherosclerosis.Mass spectrometry imaging for clinical research - latest developments, applications, and current limitations.
P2860
Q27012898-BC2EC2E8-53A0-4801-9327-509D96D24061Q28075514-241B7EA3-B569-472D-9B59-D97F18DB7E37Q28383071-360B5775-C587-4A16-81E1-140F82EB3D04Q28396816-8B15AB99-9A2C-45C2-B616-3A5DDED9C709Q28542079-93C7859A-2285-46EA-887C-9D3CDED35E00Q30938681-E6A0C507-98FF-4CD7-8C84-1579F0B9F4E1Q33591805-7E5A2757-893C-4BB1-8C03-6E31E4D3BDA1Q33722914-2BC523FA-85BE-493E-BC80-0F9B94083050Q33892773-1389CF03-C535-433B-A871-9B65E9232CD7Q33913712-85FA6A00-0743-48C2-A3F0-9575A4DFB99AQ34529048-B8371CDF-37A9-40CB-A091-682549EEEA3AQ34589419-CAAA8F4B-6381-4B00-82B3-54029E610889Q34628921-AF8DCDF7-2E9B-4A78-A5A3-2757421F269BQ34777079-51168940-6A57-4536-B4FA-F6D1930A3479Q34778073-2A5AAE6F-CCB3-43FD-9BA0-F168FFD6B582Q35117590-B4913439-B633-4B5C-9CC7-B5496C08DDE4Q35134122-BFFFCDEE-6E09-43FB-932E-E2C69F2FBD37Q35243470-7245E31E-2854-4DAE-8661-6A64ADD42BF2Q35336183-F5397054-DD72-431F-83AE-146D73863C57Q35532825-60BDA32A-1446-4BCA-B81E-F9042DC2F085Q35549222-02F434A4-1035-41BE-9FEF-A5C555D36AACQ35571593-36CC288A-31BC-4598-B04D-70088FD2096DQ35622625-2E7D344F-50D2-49F7-8AA3-2A25B0415223Q35714211-AC2C0F0C-99DB-44BC-A539-DC8F5AB466C4Q35718041-61240382-3853-4AA0-BC40-71FD0B5C6D0CQ35764430-F00DD082-437C-4E75-BA77-ACA3D659FA64Q35782287-E9D096EB-4335-4D42-A77D-F279C053E79EQ35845797-458377AD-2A1D-4F8B-9A23-C0CF0B130877Q35891644-F8619ED7-7FDB-4E36-9BA1-750F197A7B59Q35903773-2369C127-E6BA-49A8-86C8-883395652D49Q36002404-E88C9F1D-3239-40BF-8312-E592DBDD794EQ36020378-2470B71F-0CCB-430F-867B-060912895184Q36072649-8719F952-D4A0-4D8C-A939-D328E2E1D273Q36077253-D26E7222-89CA-49FC-AABC-08D879B2AA34Q36256730-1A7BE993-B177-4038-85C3-FCF42D167B89Q36321687-D486A7A9-2E8C-4D6A-BB40-A45A2D9440E6Q36884986-8722B812-19FD-4E03-A74B-F537252B5C33Q38232032-0A035500-9484-45C2-824F-14E36572823AQ38630695-83D409AE-B26D-4327-B604-880A1ED5664DQ38712870-03C1F59B-7539-43D2-ADE8-185452341A76
P2860
MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
MALDI imaging identifies progn ...... ntestinal-type gastric cancer.
@ast
MALDI imaging identifies progn ...... ntestinal-type gastric cancer.
@en
MALDI imaging identifies progn ...... ntestinal-type gastric cancer.
@nl
type
label
MALDI imaging identifies progn ...... ntestinal-type gastric cancer.
@ast
MALDI imaging identifies progn ...... ntestinal-type gastric cancer.
@en
MALDI imaging identifies progn ...... ntestinal-type gastric cancer.
@nl
prefLabel
MALDI imaging identifies progn ...... ntestinal-type gastric cancer.
@ast
MALDI imaging identifies progn ...... ntestinal-type gastric cancer.
@en
MALDI imaging identifies progn ...... ntestinal-type gastric cancer.
@nl
P2093
P2860
P1476
MALDI imaging identifies progn ...... ntestinal-type gastric cancer.
@en
P2093
Alexander Novotny
Annette Feuchtinger
Axel Walch
Benjamin Balluff
Cedrik Schöne
Christoph Schuhmacher
Giuseppina Maccarrone
Hakan Sarioglu
Heinz Höfler
Herbert Braselmann
P2860
P304
P356
10.1016/J.AJPATH.2011.08.032
P407
P577
2011-10-18T00:00:00Z